Our study shows for the first time, that Akt3 supports K-Ras(V12)-induced E-cadherin as well as NCAM expression in PANC-1 pancreatic carcinoma cells (Figs. 6, 7). This evidence concerns the gene KRAS and exocrine pancreatic carcinoma.